Articles tagged "Viral therapy"

2015 American Transplant Congress
African American Race Is an Independent Risk Factor for Cytomegalovirus Infection in Renal Transplant Recipients on Low-Dose Valganciclovir Prophylaxis
S. Patel, S. Kuten, J. Loucks-DeVos, R. Knight, A. Gaber.
Houston Methodist Hospital, Houston, TX.
Safe and effective use of low-dose (450 mg/day) valganciclovir (VGC) for cytomegalovirus (CMV) prophylaxis in renal transplant recipients (RTRs) has been reported. However, it is…
2015 American Transplant Congress
The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus (EBV) Associated Post-Transplant Lymphoproliferative Disease (PTLD) in Solid Organ Transplant Recipients: A Systematic Review
M. AlDabbagh,^1,2 M. Gitman,³ D. Kumar, A. Humar, C. Rotstein, S. Husain.^1,3
¹Medicine, Division of Infectious Diseases, University Health Network, Toronto, On, Canada; ²Pediatrics, Division of Infectious Diseases, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, Saudi Arabia; ³Multi-Organ Transplant Unit, University Health Network, Toronto, ON, Canada.
Background The role of antiviral prophylaxis in EBV seronegative solid organ transplant recipients receiving organs from seropositive donors for prevention of PTLD remains controversial. We…